November 2025: Transforming Cancer Care with Wearables

Wearable implant delivering continuous, personalized cancer therapy for everyday life.

Image credits: OptoBio

We are excited to introduce the SOMA system from OptoBio, a next-generation wearable and implantable solution designed to transform the way we treat cancer. Sleek, discreet, and built for everyday life, SOMA merges minimally-invasive implant technology with a wearable over-ear module, offering continuous, bioelectronic therapy without interrupting your routine.

Unlike treatments that tie you to hospital stays or scheduled infusions, SOMA brings targeted care directly into your daily life. With a discreet implant the size of a shirt button, ultrathin bio-threads, and an over-ear wearable that powers and monitors the system, you can receive precision therapy while remaining present in the moment.

Seamlessly integrated with the SOMA app and clinician interface, the system enables real-time data sharing, personalized adjustments, and continuous monitoring. Whether at home, at work, or on the go, it provides freedom, style, and advanced therapy without compromise.

About SOMA

Created to enhance human wellbeing through wearable and implantable healthcare technology, the SOMA system fuses design and intelligence into one seamless experience. By bringing advanced neuro-electronic and bioanalytic features into everyday therapy, OptoBio redefine how we treat, monitor, and live with cancer.

Sam Draper
November 4, 2025

November 2025

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

Kinduct and Orreco Join Hands to Develop Products for Elite Sports Teams

Kinduct, the Nova Scotia-based athlete management system has partnered up with Irish company Orreco.

Respiray: Powerful Wearable Face Mask Alternative Eliminates The Need To Cover Your Face

After the world was hit by Covid-19 pandemic, engineers at the Estonia-based Respiray began ...

Pear Therapeutics-etectRx Partnership to Develop Products Combining Medication Adherence Data with Digital Therapeutics

Digital health company etectRx has entered into an agreement with Pear Therapeutics, Inc. to...

Innovative Eyewear Announces Pricing of $7.35 Million IPO

This Initial Public Offering consists of 980,000 units consisting of 980,000 shares.
Discover more